Ethaselen: a novel organoselenium anticancer agent targeting thioredoxin reductase 1 reverses cisplatin resistance in drug-resistant K562 cells by inducing apoptosisSuofu Ye(Peking University), Huihui Zeng(Peking University)Journal of Zhejiang University SCIENCE BMay 1, 201710.1631/jzus.b1600073Cited by 32SaveCiteExport RISWatch citationsRelated PapersDevelopment and validation of a highly sensitive LC‐MS/MS method for the determination of dexamethasone in nude mice plasma and its application to a pharmacokinetic study|Biomedical Chromatography|2014|33